Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Market Analysis and Insights: Global Irritable Bowel Syndrome (IBS) Market
The global Irritable Bowel Syndrome (IBS) market is projected to grow from US$ 5508.2 million in 2024 to US$ 12740 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.0% during the forecast period.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Covers:
This report presents an overview of global market for Irritable Bowel Syndrome (IBS) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Irritable Bowel Syndrome (IBS), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Irritable Bowel Syndrome (IBS), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Irritable Bowel Syndrome (IBS) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Irritable Bowel Syndrome (IBS) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Irritable Bowel Syndrome (IBS) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Segment by Type
IBS-D Drug
IBS-C Drug
Others
Segment by Application
Women
Men
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Irritable Bowel Syndrome (IBS) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome (IBS) companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irritable Bowel Syndrome (IBS) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2019-2030)
2.2 Global Irritable Bowel Syndrome (IBS) Growth Trends by Region
2.2.1 Irritable Bowel Syndrome (IBS) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Size by Region (2019-2024)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (2025-2030)
2.3 Irritable Bowel Syndrome (IBS) Market Dynamics
2.3.1 Irritable Bowel Syndrome (IBS) Industry Trends
2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Irritable Bowel Syndrome (IBS) by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2019-2024)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2019-2024)
3.2 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Irritable Bowel Syndrome (IBS), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2023
3.5 Global Key Players of Irritable Bowel Syndrome (IBS) Head office and Area Served
3.6 Global Key Players of Irritable Bowel Syndrome (IBS), Product and Application
3.7 Global Key Players of Irritable Bowel Syndrome (IBS), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2019-2024)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2025-2030)
5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2019-2024)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
6.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type
6.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
6.2.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2025-2030)
6.2.3 North America Irritable Bowel Syndrome (IBS) Market Share by Type (2019-2030)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application
6.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
6.3.2 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2025-2030)
6.3.3 North America Irritable Bowel Syndrome (IBS) Market Share by Application (2019-2030)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country
6.4.1 North America Irritable Bowel Syndrome (IBS) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
6.4.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
7.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2025-2030)
7.2.3 Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2019-2030)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
7.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2025-2030)
7.3.3 Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2019-2030)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
7.4.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
7.4.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
8.2 China Irritable Bowel Syndrome (IBS) Market Size by Type
8.2.1 China Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
8.2.2 China Irritable Bowel Syndrome (IBS) Market Size by Type (2025-2030)
8.2.3 China Irritable Bowel Syndrome (IBS) Market Share by Type (2019-2030)
8.3 China Irritable Bowel Syndrome (IBS) Market Size by Application
8.3.1 China Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
8.3.2 China Irritable Bowel Syndrome (IBS) Market Size by Application (2025-2030)
8.3.3 China Irritable Bowel Syndrome (IBS) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
9.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Type
9.2.1 Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
9.2.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2025-2030)
9.2.3 Asia Irritable Bowel Syndrome (IBS) Market Share by Type (2019-2030)
9.3 Asia Irritable Bowel Syndrome (IBS) Market Size by Application
9.3.1 Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
9.3.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2025-2030)
9.3.3 Asia Irritable Bowel Syndrome (IBS) Market Share by Application (2019-2030)
9.4 Asia Irritable Bowel Syndrome (IBS) Market Size by Region
9.4.1 Asia Irritable Bowel Syndrome (IBS) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2024)
9.4.3 Asia Irritable Bowel Syndrome (IBS) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.1.5 Bausch Health Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.2.5 Allergan Recent Developments
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.3.5 Takeda Recent Developments
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Details
11.5.2 Sebela Pharmaceuticals Inc Business Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.5.5 Sebela Pharmaceuticals Inc Recent Developments
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Details
11.6.2 Astellas Pharmaceuticals Business Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.6.5 Astellas Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
听
听
*If Applicable.